The clinical presentation of brucellosis in humans is variable and unspecific, and thus,
laboratory corroboration of the diagnosis is essential for the patient's proper treatment. The …

The global emergence of multidrug-resistant Gram-negative bacteria is a growing threat to
antibiotic therapy. The chromosomally encoded drug efflux mechanisms that are ubiquitous …

Approximately 10% of bacterial genomes are split between two or more large DNA
fragments, a genome architecture referred to as a multipartite genome. This multipartite …

We provide here a comparative genome analysis of ten strains within the Pseudomonas
fluorescens group including seven new genomic sequences. These strains exhibit a diverse …

Drug efflux pumps play a key role in drug resistance and also serve other functions in
bacteria. There has been a growing list of multidrug and drug-specific efflux pumps …

Brucellosis, especially caused by Brucella melitensis, remains one of the most common
zoonotic diseases worldwide with more than 500,000 human cases reported annually. The …

Brucellosis is not a sustainable disease in humans. The source of human infection always
resides in domestic or wild animal reservoirs. The routes of infection are multiple: food …

Bacteria in the genus Brucella are important human and veterinary pathogens. The abortion
and infertility they cause in food animals produce economic hardships in areas where the …

Pseudomonas fluorescens Pf-5 is a plant commensal bacterium that inhabits the
rhizosphere and produces secondary metabolites that suppress soilborne plant pathogens …

A Gram-negative, non-motile, non-spore-forming coccoid bacterium (strain BO1T) was
isolated recently from a breast implant infection of a 71-year-old female patient with clinical …